Ion imbalance detector
In general, the invention is directed to methods and devices for determining an ion concentration in the extracellular fluid of a patient. As examples, the ion may be one or more of potassium, sodium, chloride, or calcium. A system includes an electrode deployed in or near a tissue, such as a skeletal muscle, of the patient. A pulse generator supplies one or more stimulations to the tissue, and a sensor, such as an accelerometer, detects the response of the tissue to the stimulations. A processor determines a concentration of ions in the extracellular fluid as a function of the response. The system may detect an ion imbalance based upon the determined concentration of ions.
1. A system comprising:
a pulse generator configured to generate an electrical stimulation;
an electrode configured to deliver the electrical stimulation to a tissue in a patient;
a sensor configured to detect a mechanical response of the tissue to the electrical stimulation; and
a processor configured to determine a concentration of ions in extracellular fluid of the patient as a function of the response.
2. The system of claim 1 , wherein the tissue is at least one of skeletal muscle, smooth muscle, cardiac muscle, or skin.
3. The system of claim 1 , wherein the ions are at least one of potassium, sodium, chloride, calcium, or magnesium ions.
4. The system of claim 1 , wherein the ions are at least one of drugs, small molecules, or endogenously charged molecules.
5. The system of claim 1 , wherein the processor is further configured to determine a concentration of ions in the extracellular fluid of the patient by at least one of determining an absolute concentration of ions in the extracellular fluid, determining a relative concentration of ions in the extracellular fluid or determining a change in concentration of ions in the extracellular fluid over time.
6. The system of claim 5 , wherein the pulse generator is configured to generate a set of electrical stimulations at a known frequency.
7. The system of claim 5 , wherein the processor is further configured to control the timing of a set of electrical stimulations generated by the pulse generator.
8. The system of claim 1 , wherein the pulse generator is further configured to generate a set of electrical stimulations.
9. The system of claim 1 , wherein the processor is further configured to determine a concentration of ions in the extracellular fluid as a function of at least one of a sustained contraction of the tissue, a rippled contraction of the tissue, a rate of relaxation of the tissue, a pulse width of the response, the occurrence of summation in the response or the amplitude of the response.
10. The system of claim 1 , wherein the electrode is a first electrode, the system further comprising a housing and a second electrode in the housing.
11. The system of claim 1 , wherein the sensor comprises at least one of an optical sensor, an accelerometer, a pressure sensor, or a piezoelectric sensor.
12. The system of claim 1 , wherein the processor is further configured to control delivery of pacing therapy to a heart of the patient.
13. The system of claim 1 , further comprising a lead configured to couple the electrode to the pulse generator.
14. The system of claim 1 , wherein the system further comprises at least one of a lead configured to deliver a pacing stimulation to a heart, a lead configured to deliver a pacing stimulation to a nerve, or a pump configured to deliver a drug from a reservoir.
15. The system of claim 1 , wherein at least one of the pulse generator, electrode, sensor and processor is configured to be implanted in a human or animal body.
16. The system of claim 1 , wherein the processor monitors the concentration of ions to predict an arrhythmia.
17. A method comprising:
delivering an electrical stimulation to a tissue in a patient;
detecting a response of the tissue to the electrical stimulation; and
determining a concentration of ions in extracellular fluid of the patient as a function of the response,
wherein the tissue is at least one of skeletal muscle, smooth muscle, cardiac muscle, nerve tissue, or skin.
18. The method of claim 17 , wherein the ions are at least one of potassium, sodium, chloride, calcium, or magnesium ions.
19. The method of claim 17 , wherein the ions are at least one of drugs, small molecules, or endogenously charged molecules.
20. The method of claim 17 , wherein determining the concentration of ions in the extracellular fluid of the patient comprises at least one of determining an absolute concentration of ions in the extracellular fluid, determining a relative concentration of ions in the extracellular fluid, or determining a change in concentration of ions in the extracellular fluid over time.
21. The method of claim 17 , wherein determining the concentration of ions in the extracellular fluid of the patient comprises at least one of detecting a sustained contraction of the tissue, detecting a rippled contraction of the tissue, detecting a rate of relaxation of the tissue, detecting a pulse width of the response, detecting the occurrence of summation in the response, or detecting the amplitude of the response.
22. The method of claim 17 , further comprising delivering a therapy to the patient as a function of the response.
23. The method of claim 17 , wherein the electrical stimulation is a first electrical stimulation and the response is a first response, the method further comprising:
delivering a second electrical stimulation to the tissue;
detecting a second response of the tissue to the second electrical stimulation; and
determining a change in concentration of ions in the extracellular fluid of the patient as a function of the first and second responses.
24. The method of claim 17 , further comprising:
detecting a triggering event; and
delivering the electrical stimulation in response to the triggering event.
25. The method of claim 17 , further comprising:
determining whether conditions are suitable for determining the concentration of ions; and
delivering the electrical stimulation when the conditions are suitable.
26. The method of claim 17 , further comprising monitoring the concentration of ions to predict an arrhythmia.
27. The method of claim 17 , further comprising at least one of recording information relating to the determination, or issuing a warning to at least one of the patient or a caregiver based upon the determination.
28. The method of claim 17 , further comprising transmitting information relating to the determination to another device.
29. A non-transitory computer-readable medium comprising instructions that cause a programmable processor to:
control a pulse generator to deliver an electrical stimulation to a tissue in a patient;
receive from a sensor a signal indicative of a mechanical response of the tissue to the electrical stimulation; and
determine a concentration of ions in extracellular fluid of the patient as a function of the response.
30. The medium of claim 29 , wherein the tissue is at least one of skeletal muscle, smooth muscle, or skin.
31. The medium of claim 29 , wherein the ions are at least one of potassium, sodium, chloride, calcium, or magnesium ions.
32. The medium of claim 29 , wherein the ions are at least one of drugs, small molecules, or endogenously charged molecules.
33. The medium of claim 29 , the instructions further causing the processor to determine the concentration of ions in the extracellular fluid by determining a change in concentration of ions in the extracellular fluid over time.
34. The medium of claim 29 , the instructions further causing the processor to determine the concentration of ions in the extracellular fluid by at least one of detecting a sustained contraction of the tissue, detecting a rippled contraction of the tissue, detecting a rate of relaxation of the muscle, detecting a pulse width of the response, detecting the occurrence of summation in the response, or detecting the amplitude of the response.
35. The medium of claim 29 , the instructions further causing the processor to control delivery of a therapy to the patient as a function of the response.
36. The medium of claim 29 , further comprising instructions that cause the programmable processor to monitor the concentration of ions to predict an arrhythmia.
37. A system comprising:
means for delivering an electrical stimulation to a tissue in a patient;
means for detecting a response of the tissue to the electrical stimulation; and
means for determining a concentration of ions in extracellular fluid of the patient as a function of the response,
wherein the tissue comprises at least one of skeletal muscle, smooth muscle, cardiac muscle, nerve tissue, and skin.
38. The system of claim 37 , further comprising means for delivering therapy to the patient as a function of the response.
39. The system of claim 37 , further comprising means for monitoring the concentration of ions to predict an arrhythmia.
40. A method comprising:
delivering an electrical stimulation to a tissue in a patient;
detecting a mechanical response of the tissue to the electrical stimulation; and
determining a concentration of ions in extracellular fluid of the patient as a function of the response.